D-0652-2024 Class II Ongoing

Recalled by ProRx LLC — Exton, PA

FDA drug recall D-0652-2024 was initiated by ProRx LLC on Aug 22, 2024 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 8,396 vials.

Recall details

Product Type
Drugs
Report Date
Sep 11, 2024
Initiation Date
Aug 22, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,396 vials

Product description

SEMAGLUTIDE 5mg/2mL (2.5mg/mL), Rx Only 2 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-01

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide in the USA

Code information

Lot #: ProRx052424, BUD 11/23/2024 ProRx060724, BUD 12/06/2024 ProRx061124, BUD 12/10/2024 ProRx061924, BUD 12/18/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0652-2024
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0652-2024. Report a data issue: hello@regdatalab.com.